SCHEMBL2461

SCHEMBL2461

CC(C)CC1CC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21775731 1.00 OPRK1 (0.34) —
SCHEMBL3956724 0.91 OPRK1 (0.42) —
Ammonia Solution, Strong SCHEMBL689783 0.88 OPRK1 (0.41) —
SCHEMBL170562 0.87 — —
SCHEMBL198169 0.87 — —
SCHEMBL102088 0.86 CPB2 (0.33) —
SCHEMBL22275536 0.86 NCF1 (0.42) —
SCHEMBL6759381 0.86 SHBG (0.41) —
SCHEMBL22275535 0.86 NCF1 (0.42) —
SCHEMBL13444937 0.86 OPRK1 (0.30) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 167 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023141852-A1 CDK2 INHIBITORS, PREPARATION METHOD THEREFOR AND USE THEREOF 益方生物科技(上海)股份有限公司 2023-08-03 — — WO claimed
EP-3256448-A1 SUBSTITUTED 1-CYCLOALKYL-2-OXOTETRAHYDROQUINOLIN-6-YL-SULFONAMIDES OR SALTS THEREOF AND USE THEREOF TO INCREASE STRESS TOLERANCE IN PLANTS Bayer CropScience Aktiengesellschaft (DE) 2017-12-20 — — EP claimed
WO-2016128365-A1 SUBSTITUTED 1-CYCLOALKYL-2-OXOTETRAHYDROQUINOLIN-6-YL-SULFONAMIDES OR SALTS THEREOF AND USE THEREOF TO INCREASE STRESS TOLERANCE IN PLANTS BAYER CROPSCIENCE AKTIENGESELLSCHAFT (DE) 2016-08-18 — — WO claimed
CN-104203993-B Process for producing olefin polymer 三井化学株式会社 2016-06-15 — — CN claimed
EP-2155719-A1 AZACYCLYLBENZAMIDE DERIVATIVES AS HISTAMINE-3 ANTAGONISTS Wyeth LLC (US) 2010-02-24 — — EP claimed
WO-2008147945-A1 AZACYCLYLBENZAMIDE DERIVATIVES AS HISTAMINE-3 ANTAGONISTS WYETH (US) 2008-12-04 — — WO claimed
US-20080293701-A1 1-Acylamino-2-Hydroxy-3-Amino- -Arylalkanes as Renin Inhibitors VITAE PHARMACEUTICALS, INC. 2008-11-27 — — US claimed
EP-1844002-A1 1-ACYLAMINO-2-HYDROXY-3-AMINO-W-ARYLALKANES AS RENIN INHIBITORS Vitae Pharmaceuticals, Inc. (US) 2007-10-17 — — EP claimed
WO-2006083924-A1 1-ACYLAMINO-2-HYDROXY-3-AMINO-W-ARYLALKANES AS RENIN INHIBITORS VITAE PHARMACEUTICALS, INC. (US) 2006-08-10 — — WO claimed
CN-112812014-B Compound, liquid crystal composition and liquid crystal display 石家庄诚志永华显示材料有限公司 2024-05-10 — — CN disclosed
CN-112480937-B Liquid crystal compound, liquid crystal composition, liquid crystal display element, and liquid crystal display 石家庄诚志永华显示材料有限公司 2024-04-02 — — CN disclosed
US-11912693-B2 Compounds for modulating S1P1 activity and methods of using the same TREVENA, INC. (US) 2024-02-27 — — US disclosed
CN-113004906-B Liquid crystal compound and application thereof 石家庄诚志永华显示材料有限公司 2024-01-05 — — CN disclosed
CN-113354607-B Negative liquid crystal compound, liquid crystal composition, liquid crystal display element and liquid crystal display 石家庄诚志永华显示材料有限公司 2023-12-05 — — CN disclosed
EP-0173331-A2 2,3-Dihydro-1H-indene derivatives, a process for preparing them and pharmaceutical compositions containing same OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1986-03-05 — — EP disclosed
US-4522828-A CYCLOBUTYLALKYLAMINE COMPOUNDS, ANTIDEPRESSANTS THE BOOTS COMPANY PLC (GB) 1985-06-11 — — US disclosed
EP-0069811-B1 BRANCHED AMIDES OF L-ASPARTYL-D-AMINO ACID DIPEPTIDES AND COMPOSITIONS THEREOF PFIZER INC. (US) 1984-10-24 — — EP disclosed
US-4399163-A ARTIFICIAL SWEETENERS PFIZER INC. (US) 1983-08-16 — — US disclosed
US-4152358-A FROM ALIPHATIC, AROMATIC OR ALICYCLIC HYDROCARBON IN PRESENCE OF PHOSPHATE OF URANIUM, COPPER OR IRON PETRO-TEX CHEMICAL CORPORATION (US) 1979-05-01 — — US disclosed
US-3974228-A BUFFERS PETRO-TEX CHEMICAL CORPORATION (US) 1976-08-10 — — US disclosed
Send feedback